Antidrug antibody formation during tumor necrosis factor α inhibitor treatment of severe psoriatic patients in the real-life practice

INTRODUCTION: Antidrug antibody (ADA) production may be the reason behind secondary inefficacy of anti-TNF-α therapy in psoriasis. AIM: To investigate the production of ADA, serum tumor necrosis factor α (TNF-α) and drug levels as predictors of clinical response in real-life circumstances. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Herszényi, Krisztina, Jókai, Hajnalka, Rencz, Fanni, Brodszky, Valentin, Nagy, Eszter, Holló, Péter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906958/
https://www.ncbi.nlm.nih.gov/pubmed/31839776
http://dx.doi.org/10.5114/ada.2019.89507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906958/
https://www.ncbi.nlm.nih.gov/pubmed/31839776
http://dx.doi.org/10.5114/ada.2019.89507

Ejemplares similares